We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$915M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$161M |
| 2 |
Church & Dwight Co
CHD
|
+$150M |
| 3 |
Advanced Micro Devices
AMD
|
+$78.9M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$56.9M |
| 5 |
AstraZeneca
AZN
|
+$53.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$170M |
| 2 |
AT&T
T
|
+$142M |
| 3 |
Microsoft
MSFT
|
+$136M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$110M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Custom Truck One Source
CTOS
$2.47B
| $92K | ﹤0.01% |
10,985
+889
| +9% | +$7.18K |
|
2052
Rayonier Advanced Materials
RYAM
$565M
| $92K | ﹤0.01% |
13,809
-1,686
| -11% | -$10.3K |
|
|
RAD
2053
DELISTED
Rite Aid Corporation
RAD
| $92K | ﹤0.01% |
10,522
-1,732
| -14% | -$18.1K |
|
2054
Kodiak Sciences
KOD
$2.59B
| $90K | ﹤0.01% |
11,623
-2,975
| -20% | -$116K |
|
|
GTHX
2055
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $90K | ﹤0.01% |
11,849
-2,798
| -19% | -$26.5K |
|
|
MRSN
2056
DELISTED
Mersana Therapeutics
MRSN
| $88K | ﹤0.01% |
882
-149
| -14% | -$17.4K |
|
|
AEVA
2057
Aeva Technologies
AEVA
$1.02B
| $86K | ﹤0.01% |
3,967
-645
| -14% | -$15.8K |
|
2058
PureCycle Technologies
PCT
$1.17B
| $86K | ﹤0.01% |
10,738
-930
| -8% | -$6.79K |
|
2059
Babcock & Wilcox
BW
$1.43B
| $85K | ﹤0.01% |
10,409
-1,715
| -14% | -$13.4K |
|
2060
AtaiBeckley Inc
ATAI
$2.66B
| $84K | ﹤0.01% |
16,589
-5,984
| -27% | -$33.3K |
|
2061
Stagwell
STGW
$1.84B
| $84K | ﹤0.01% |
11,565
-1,906
| -14% | -$14.3K |
|
|
KLRS
2062
Kalaris Therapeutics
KLRS
$88.7M
| $84K | ﹤0.01% |
534
-145
| -21% | -$28.9K |
|
|
ME
2063
DELISTED
23andMe Holding Co
ME
| $84K | ﹤0.01% |
1,093
+227
| +26% | +$20.7K |
|
2064
Cogent Biosciences
COGT
$6.79B
| $83K | ﹤0.01% |
11,101
-2,633
| -19% | -$18.3K |
|
2065
The Honest Company
HNST
$417M
| $83K | ﹤0.01% |
15,950
-2,634
| -14% | -$15.9K |
|
|
ORC
2066
Orchid Island Capital
ORC
$1.31B
| $83K | ﹤0.01% |
5,097
-843
| -14% | -$15.9K |
|
2067
Precigen
PGEN
$1.93B
| $83K | ﹤0.01% |
39,177
-10,624
| -21% | -$25.9K |
|
|
ESPR
2068
DELISTED
Esperion Therapeutics
ESPR
| $81K | ﹤0.01% |
17,332
+7,317
| +73% | +$31.4K |
|
2069
SelectQuote
SLQT
$114M
| $81K | ﹤0.01% |
29,473
-3,717
| -11% | -$17.9K |
|
2070
Outdoor Holding Co
POWW
$239M
| $80K | ﹤0.01% |
16,621
-2,432
| -13% | -$11.4K |
|
2071
Amneal Pharmaceuticals
AMRX
$5.72B
| $78K | ﹤0.01% |
18,706
-3,076
| -14% | -$13.6K |
|
|
JNCE
2072
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $78K | ﹤0.01% |
11,484
-2,933
| -20% | -$20.9K |
|
|
CBAY
2073
DELISTED
Cymabay Therapeutics
CBAY
| $76K | ﹤0.01% |
24,721
-2,344
| -9% | -$7.38K |
|
|
BLU
2074
DELISTED
BELLUS Health Inc.
BLU
| $76K | ﹤0.01% |
11,012
-19
| -0.2% | -$122 |
|
|
CTLP
2075
DELISTED
Cantaloupe
CTLP
| $75K | ﹤0.01% |
10,929
-1,802
| -14% | -$13.7K |
|
Similar funds
ProShare Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
- ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
- ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
- ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
- ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
- ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
- ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.
Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.